Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.

Also called NCT03906799

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 136 participants (enrolled count) (from the registry)
Sponsor
Omeicos Therapeutics GmbH (from the registry)
Registry
  • NCT NCT03906799
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Bulgaria, Czechia, Hungary, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03906799. Randomized; triple masking; primary purpose treatment. Start 2019-03-19 (actual); primary completion 2019-11-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
Acronym
PROMISE-AF
Intervention (Drug)
OMT-28
Intervention (Drug)
Placebo
Lead sponsor
Omeicos Therapeutics GmbH (class: industry)

Record details

Record id
cardio:ct-nct03906799
Content hash
cec0bc0cc936137049d3e0f53d1d8ba82261d97d87294c922392a8ede0f3946a